FDA Drug Safety Information for February 5, 2024

Feb 052024
 

Date Brand Name(s) Description Type Reason Company  2/5/2024 Sustain, Schwinnng Sustain and Schwinnng brand male enhancement capsules Drugs Products contain undeclared Tadalafil and Nortadalafil Today

FDA Drug Safety Information for February 2, 2024

Feb 022024
 

Date Brand Name(s) Description Type Reason Company  2/2/2024 TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Drugs Presence of benzene Insight Pharmaceuticals

FDA Novel Drug Approvals – January 2024

Feb 012024
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Zelsuvmi berdazimer 1/5/2024 To treat molluscum contagiosum Drug Trials

FDA Drug Safety Information for January 29, 2024

Jan 292024
 

Date Brand Name(s) Description Type Reason Company  1/29/2024 Neptune’s Fix Neptune’s Fix Elixir, Neptune’s Fix Extra Strength Elixir, and Neptune’s Fix Tablets Drugs Undeclared Tianeptine

FDA Drug Safety Information for January 23, 2024

Jan 232024
 

Date Brand Name(s) Description Type Reason Company  1/23/2024 Aligned Medical Solutions Convenience kits containing saline Medical Devices Product cannot be verified as having the required

FDA Drug Safety Information for January 22, 2024

Jan 222024
 

Date Brand Name(s) Description Type Reason Company  22-Jan-2024 Multiple brands Lubricant Eye Drops & Multi-Symptom Eye Drops Drugs Device & Drug Safety Potential Safety Concerns

Updated Drug Shortage Information for January 22, 2024

Jan 222024
 

Shortage updates January 22, 2024 Amoxicillin Powder, For Suspension (Currently in Shortage) Conivaptan Hydrochloride Injection (Discontinuation) Heparin Sodium Injection (Currently in Shortage) Multi-Vitamin Infusion (Adult and Pediatric) Injection (Resolved)

 Older Entries  Newer Entries